Generative AI can be used to combat misinformation. However, it can also exacerbate the problem by producing convincing ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - ...
Enterprise AI adoption looks strong, but real ROI lags. Why coordination theater, shadow IT and stalled redesign are distorting compounding value.
Explore the parallels and differences between AI architectures and the human brain's design and functionality in processing ...
Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.
The World Economic Forum's Global Risks Report 2025 identified 7 of the top 10 long-term business risks as ESG-related.
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
The recent Public Services Association (PSA) wage settlement could have far-reaching implications for Trinidad and Tobago’s ...
Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.
Complete relief pitcher rankings with 2026 projections and player-by-player analysis.
Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according to trialists.
Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results